Debanjana Chatterjee

Stock Analyst at Jones Trading

(n/a)
# 4,350
Out of 4,711 analysts
4
Total ratings
n/a
Success rate
-25.32%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Debanjana Chatterjee

Spyre Therapeutics
Dec 11, 2024
Initiates: Hold
Price Target: n/a
Current: $23.86
Upside: -
KalVista Pharmaceuticals
Sep 27, 2024
Initiates: Buy
Price Target: $35
Current: $8.36
Upside: +318.66%
Pharvaris
Sep 19, 2024
Initiates: Buy
Price Target: $46
Current: $19.57
Upside: +135.05%
Intellia Therapeutics
Sep 17, 2024
Initiates: Buy
Price Target: $41
Current: $12.18
Upside: +236.62%